These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 19455069)
21. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status. Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA; JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844 [TBL] [Abstract][Full Text] [Related]
22. Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone: Analyses of Data From 2 Women's Health Initiative Randomized Clinical Trials. Chlebowski RT; Rohan TE; Manson JE; Aragaki AK; Kaunitz A; Stefanick ML; Simon MS; Johnson KC; Wactawski-Wende J; O'Sullivan MJ; Adams-Campbell LL; Nassir R; Lessin LS; Prentice RL JAMA Oncol; 2015 Jun; 1(3):296-305. PubMed ID: 26181174 [TBL] [Abstract][Full Text] [Related]
23. Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsy. Chlebowski RT; Anderson G; Pettinger M; Lane D; Langer RD; Gilligan MA; Walsh BW; Chen C; McTiernan A; Arch Intern Med; 2008 Feb; 168(4):370-7; quiz 345. PubMed ID: 18299491 [TBL] [Abstract][Full Text] [Related]
24. Different menopausal hormone regimens and risk of breast cancer. Brusselaers N; Tamimi RM; Konings P; Rosner B; Adami HO; Lagergren J Ann Oncol; 2018 Aug; 29(8):1771-1776. PubMed ID: 29917061 [TBL] [Abstract][Full Text] [Related]
25. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. Schairer C; Lubin J; Troisi R; Sturgeon S; Brinton L; Hoover R JAMA; 2000 Jan; 283(4):485-91. PubMed ID: 10659874 [TBL] [Abstract][Full Text] [Related]
26. Mammographic breast density during hormone replacement therapy: differences according to treatment. Lundström E; Wilczek B; von Palffy Z; Söderqvist G; von Schoultz B Am J Obstet Gynecol; 1999 Aug; 181(2):348-52. PubMed ID: 10454681 [TBL] [Abstract][Full Text] [Related]
27. Postmenopausal hormone therapy with estradiol and norethisterone acetate and mammographic density: findings from a cross-sectional study among Norwegian women. Stuedal A; Ma H; Bjørndal H; Ursin G Climacteric; 2009 Jun; 12(3):248-58. PubMed ID: 19387884 [TBL] [Abstract][Full Text] [Related]
28. Mammographic Density Change With Estrogen and Progestin Therapy and Breast Cancer Risk. Byrne C; Ursin G; Martin CF; Peck JD; Cole EB; Zeng D; Kim E; Yaffe MD; Boyd NF; Heiss G; McTiernan A; Chlebowski RT; Lane DS; Manson JE; Wactawski-Wende J; Pisano ED J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28376149 [TBL] [Abstract][Full Text] [Related]
29. Breast cancer risk with postmenopausal hormonal treatment. Collins JA; Blake JM; Crosignani PG Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813 [TBL] [Abstract][Full Text] [Related]
30. Case-control study of increased mammographic breast density response to hormone replacement therapy. Vachon CM; Sellers TA; Vierkant RA; Wu FF; Brandt KR Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1382-8. PubMed ID: 12433715 [TBL] [Abstract][Full Text] [Related]
31. Predictors of breast density change after hormone therapy cessation: results from a randomized trial. Lowry SJ; Aiello Bowles EJ; Anderson ML; Buist DS Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2309-12. PubMed ID: 21813728 [TBL] [Abstract][Full Text] [Related]
32. Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography. Laya MB; Larson EB; Taplin SH; White E J Natl Cancer Inst; 1996 May; 88(10):643-9. PubMed ID: 8627640 [TBL] [Abstract][Full Text] [Related]
33. Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. Stefanick ML; Anderson GL; Margolis KL; Hendrix SL; Rodabough RJ; Paskett ED; Lane DS; Hubbell FA; Assaf AR; Sarto GE; Schenken RS; Yasmeen S; Lessin L; Chlebowski RT; JAMA; 2006 Apr; 295(14):1647-57. PubMed ID: 16609086 [TBL] [Abstract][Full Text] [Related]
34. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. Glass AG; Lacey JV; Carreon JD; Hoover RN J Natl Cancer Inst; 2007 Aug; 99(15):1152-61. PubMed ID: 17652280 [TBL] [Abstract][Full Text] [Related]
35. Hormone therapy, timing of initiation, and cognition in women aged older than 60 years: the REMEMBER pilot study. MacLennan AH; Henderson VW; Paine BJ; Mathias J; Ramsay EN; Ryan P; Stocks NP; Taylor AW Menopause; 2006; 13(1):28-36. PubMed ID: 16607096 [TBL] [Abstract][Full Text] [Related]
36. Postmenopausal hormone therapy and change in mammographic density. Greendale GA; Reboussin BA; Slone S; Wasilauskas C; Pike MC; Ursin G J Natl Cancer Inst; 2003 Jan; 95(1):30-7. PubMed ID: 12509398 [TBL] [Abstract][Full Text] [Related]
37. Different types of postmenopausal hormone therapy and mammographic density in Norwegian women. Bremnes Y; Ursin G; Bjurstam N; Lund E; Gram IT Int J Cancer; 2007 Feb; 120(4):880-4. PubMed ID: 17131324 [TBL] [Abstract][Full Text] [Related]
38. Factors associated with successful discontinuation of hormone therapy. Newton KM; Reed SD; Nekhyludov L; Grothaus LC; Ludman EJ; Ehrlich K; LaCroix AZ J Womens Health (Larchmt); 2014 May; 23(5):382-8. PubMed ID: 24443881 [TBL] [Abstract][Full Text] [Related]
39. Estrogen affects post-menopausal women differently than estrogen plus progestin replacement therapy. Tannen RL; Weiner MG; Xie D; Barnhart K Hum Reprod; 2007 Jun; 22(6):1769-77. PubMed ID: 17347166 [TBL] [Abstract][Full Text] [Related]
40. Reliable evidence from placebo-controlled, randomized, clinical trials for menopausal hormone therapy's influence on incidence and deaths from breast cancer. Chlebowski RT; Anderson GL; Prentice RL; Rossouw JE; Aragaki AK; Manson JE Climacteric; 2015 Jun; 18(3):336-8. PubMed ID: 25966858 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]